Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price shot up 5.9% during trading on Friday . The stock traded as high as GBX 1.97 ($0.03) and last traded at GBX 1.80 ($0.02). 2,141,352 shares were traded during trading, an increase of 57% from the average session volume of 1,367,414 shares. The stock had previously closed at GBX 1.70 ($0.02).
Cizzle Biotechnology Stock Performance
The firm has a market capitalization of £7.86 million, a price-to-earnings ratio of -180.00 and a beta of 0.36. The business’s 50-day moving average is GBX 1.81 and its two-hundred day moving average is GBX 1.82.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Stories
- Five stocks we like better than Cizzle Biotechnology
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Leveraged ETFs to Multiply Returns
- What is the Shanghai Stock Exchange Composite Index?
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- Canada Bond Market Holiday: How to Invest and Trade
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
